KLAR — Klaria Pharma Holding AB (publ) Share News
0.000.00%
Last trade - 00:00- SEK123.23m
- SEK124.47m
- SEK8.99m
Brief: Klaria Acquires Uppsalagruppen And Becomes Owner Of Patent
Brief: Klaria Pharma Holding Announces Founding Of New Company Cannabis Delivery Sciences
Brief: Klaria Announces Positive Results In Pre-Clinical Study With Transmucosal Oral Film Of Ketamine
Brief: Klaria Pharma Holding Buys WBC Drug Delivery Technologies
Brief: Klaria Re-Acquires Global Rights For Naloxone Project
Brief: Klaria Pharma Q2 Loss After Tax Narrows To SEK 7.9 Mln
Brief: Klaria: Positive Pre-Clinical Results With Cannabinoid CBD
Brief: Klaria Pharma Q1 Net Loss Narrows To SEK 2.1 Mln
Brief: Klaria Submits Cannabinoid Formulation Patent Application
Brief: Klaria Pharma Holding Q4 Net Loss Sek 15.3 Million
Brief: Klaria Pharma Q4 Net Loss Widens To SEK 15.3 Million
Brief: Klaria Signs Exclusive Development, License And Supply Agreements With Purdue Pharma (Canada)
Brief: Klaria Signs Exclusive Development, License And Supply Agreements With Purdue Pharma
Brief: Klaria Pharma Holding Q3 Operating Loss Widens To SEK 3.7 Million
Brief: Klaria Signs Agreement For EU Grant Worth CA. 21 Msek To Take Migraine Product To Market
Brief: Klaria Pharma Gets EU Horizon2020 Grant of About EUR 2 Mln
Brief: Klaria Pharma Holding Q2 Net Loss Widens To SEK 4.5 Mln
Brief: Klaria Pharma Q1 Operating Loss Widens To SEK 3.8 Million
Brief: Klaria Pharma Q4 Pre-Tax Loss Widesn To Sek 4.2 Million